- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13.02. | TriNetX and Fujitsu form JV to boost healthcare research in Japan | ||
| 13.02. | AbbVie and Xilio to collaborate on antibody-based immunotherapies | ||
| 12.02. | Abcuro secures $200m as it eyes approval for rare muscle disease drug | ||
| 12.02. | OCT West Coast 2025: China surpasses US for annual number of clinical trials | ||
| 12.02. | Lundbeck gains FDA fast track designation for MSA therapy amlenetug | ||
| 12.02. | FDA approves Gomekli as first neurofibromatosis drug for adults | ||
| 12.02. | Travere takes rare disease kidney drug to FDA despite failed trial | ||
| 12.02. | EC grants marketing authorisation to BridgeBio's ATTR-CM treatment | ||
| 12.02. | Health Canada approves MSD's Keytruda for NSCLC stages | ||
| 11.02. | Be realistic, responsive and transparent: how to engage underperforming sites | ||
| 11.02. | UK awards £82.6m to AI drug discovery companies | ||
| 11.02. | WHO and St Jude start distributing paediatric cancer medicines amid US aid cuts | ||
| 11.02. | Grace Therapeutics secures $15m for GTx-104 pre-commercial development | ||
| 11.02. | Eli Lilly pledges $630m on OliX's Phase I RNA candidate for MASH | ||
| 11.02. | Novartis signs agreement to acquire Anthos for $925m upfront | ||
| 11.02. | Obesity market to reach $173.5 billion by 2031 | ||
| 11.02. | Bio-Thera signs US deal with Intas for golimumab biosimilar | ||
| 10.02. | Boehringer seeks approval of lung disease drug after second Phase III success | ||
| 10.02. | Public health strategies skip patients with rare diseases, says UK study | ||
| 10.02. | Keymed's Stapokibart approved by NMPA for seasonal allergic rhinitis | ||
| 10.02. | Fourth person receives eGenesis' gene-edited pig kidney transplant | ||
| 10.02. | Super Bowl ad for copycat weight loss drugs stokes pharma power debate | ||
| 10.02. | Eton secures US patent for diabetes insipidus treatment | ||
| 10.02. | FDA approves AbbVie's Emblaveo for intra-abdominal infections | ||
| 07.02. | Bain Capital buys Mitsubishi Tanabe Pharma for $3.3bn |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
